February 11, 2020 / 7:18 AM / 11 days ago

BRIEF-Infant Bacterial Therapeutics Q4 Operating Loss Widens To SEK 27.4 Mln

Feb 11 (Reuters) - Infant Bacterial Therapeutics AB :

* Q4 OPERATING LOSS SEK 27.4 MILLION VERSUS LOSS SEK 23.8 MILLION YEAR AGO

* BOARD OF DIRECTORS PROPOSE THAT NO DIVIDEND BE PAID FOR FISCAL YEAR 2019 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below